Private Equity Firm Healthcare

H.I.G. HealthBridge

United States

Formerly known as H.I.G. BioHealth, H.I.G. BioHealth Partners, H.I.G. Capital

Life-sciences-focused investment affiliate/vehicle of H.I.G. Capital, specializing in healthcare and biotech investments (now branded as H.I.G. HealthBridge).

Focus Areas
Life sciences / biohealth investments, Healthcare / biotech investments

Tracked deals

9

9 tracked deals across 2019-2025.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

6 buyout · 1 addon · 1 growth capital

H.I.G. HealthBridge Acquisition Volume by Year

Last 4 years

Acquisition volume by year Annual acquisition counts for the last 4 years for H.I.G. HealthBridge. 2 2019 4 2021 2 2022 1 2025

Supporting Data

Recent Transactions

  • GetixHealth (H.I.G. Portfolio Company) Acquires Americollect
    June 23, 2025
    Buyer
    GetixHealth, H.I.G. Capital
    Target
    Americollect
    Industry
    Healthcare Services
    Location
    Wisconsin, United States
    Type
    Addon

    GetixHealth, a portfolio company of H.I.G. Capital, has completed the acquisition of Americollect, a Manitowoc, Wisconsin-based provider of patient engagement solutions. The deal expands GetixHealth's revenue cycle management (RCM) capabilities and patient financial engagement offerings, with H.I.G. supporting continued investment in technology and scalable operations.

  • H.I.G. Capital Acquires Celerion
    November 3, 2022
    Buyer
    H.I.G. Capital
    Target
    Celerion Holdings, Inc.
    Industry
    Healthcare Services
    Location
    Nebraska, United States
    Type
    Buyout

    H.I.G. Capital (through an affiliate) completed the acquisition of Celerion Holdings, Inc., a global clinical research organization headquartered in Lincoln, Nebraska. Celerion provides end-to-end early-stage clinical trial and bioanalytical services to pharmaceutical and biotechnology clients; H.I.G. said the investment expands its pharma services platform and supports Celerion's growth plans.

  • H.I.G. Capital Recapitalizes Navitas Life Sciences
    September 13, 2022
    Buyer
    H.I.G. Capital
    Target
    Navitas Life Sciences
    Seller
    TAKE Solutions Limited
    Industry
    Healthcare Services
    Location
    New Jersey, United States
    Type
    Recapitalization

    An affiliate of H.I.G. Capital completed the recapitalization of Navitas Life Sciences, a Princeton, New Jersey–based technology-enabled clinical research organization (CRO). The transaction follows H.I.G.'s earlier agreement to acquire a majority (~75%) stake from TAKE Solutions and will provide Navitas with capital and resources to accelerate growth and expand its technology-enabled CRO capabilities.

  • H.I.G. Capital Makes Strategic Equity Investment in Rising Pharmaceuticals
    December 13, 2021
    Buyer
    H.I.G. Capital
    Target
    Rising Pharma Holdings, Casper Pharma
    Industry
    Pharmaceuticals
    Location
    New Jersey, United States
    Type
    Growth capital

    An affiliate of H.I.G. Capital has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (together, Rising Pharmaceuticals) to support the company's growth, M&A activity and new product launches. Rising Pharmaceuticals is an asset-light developer and marketer of generic and specialty pharmaceuticals based in New Jersey with a diversified portfolio of over 125 products and a network of 23+ CMO/CDO partners.

  • Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters
    November 9, 2021
    Buyer
    Welsh, Carson, Anderson & Stowe, Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures, UNC Health, Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
    Target
    Leiters
    Seller
    Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors, H.I.G. BioHealth Partners
    Industry
    Pharmaceuticals
    Location
    Colorado, United States
    Type
    Buyout

    Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.

  • H.I.G. Capital Acquires Aspire Pharma Limited
    September 24, 2021
    Buyer
    H.I.G. Capital
    Target
    Aspire Pharma Limited
    Industry
    Pharmaceuticals
    Location
    Hampshire, United Kingdom
    Type
    Buyout

    An affiliate of H.I.G. Capital has acquired Aspire Pharma Limited, a UK-based developer and licensor of niche generic and branded specialty pharmaceuticals. Founder Graham Fraser-Pye remains with the business as chairman; financial terms were not disclosed and H.I.G. said it will support Aspire's organic growth, M&A activity and international expansion.

  • H.I.G. Capital Acquires Brazilian Pet Food Manufacturer FVO
    February 11, 2021
    Buyer
    H.I.G. Capital
    Target
    FVO – Brasília Indústria e Comércio de Alimentos LTDA
    Industry
    Food & Beverage
    Location
    Federal District, Brazil
    Type
    Buyout

    H.I.G. Capital completed the acquisition of FVO – Brasília Indústria e Comércio de Alimentos LTDA, a leading Brazilian pet food manufacturer with nationwide reach. The purchase gives H.I.G. a platform in the attractive Brazilian pet food market — FVO operates five production plants, nine distribution centers and serves all 27 Brazilian states.

  • H.I.G. Capital Acquires BioVectra Inc.
    November 4, 2019
    Buyer
    H.I.G. Capital
    Target
    BioVectra Inc.
    Seller
    Mallinckrodt plc
    Industry
    Pharmaceuticals
    Location
    Prince Edward Island, Canada
    Type
    Buyout

    H.I.G. Capital, through an affiliate, completed the acquisition of BioVectra Inc., a Canadian contract development and manufacturing organization (CDMO) specializing in active pharmaceutical ingredients (APIs), intermediates and biologics. The deal — a carve-out from Mallinckrodt — positions H.I.G. to support BioVectra's growth and further expand its manufacturing capabilities across Charlottetown, Prince Edward Island and Windsor, Nova Scotia.

  • H.I.G. Capital Acquires Taconic Biosciences
    February 7, 2019
    Buyer
    H.I.G. Capital, H.I.G. BioHealth Partners
    Target
    Taconic Biosciences, Inc.
    Industry
    Healthcare Services
    Location
    New York, United States
    Type
    Buyout

    H.I.G. Capital, through an affiliate, has completed the acquisition of Taconic Biosciences, a global provider of genetically engineered research models and related services. The private equity investment will partner with Taconic's management to support geographic expansion, broaden product and service offerings, and accelerate M&A-driven growth.

Related Acquisition Pages

Healthcare Services Buyers & Acquisitions 4 tracked deals by H.I.G. HealthBridge. Pharmaceuticals Buyers & Acquisitions 4 tracked deals by H.I.G. HealthBridge. Food & Beverage Buyers & Acquisitions 1 tracked deal by H.I.G. HealthBridge. Acquisitions in New Jersey 2 tracked deals by H.I.G. HealthBridge. Acquisitions in Colorado 1 tracked deal by H.I.G. HealthBridge. Acquisitions in Nebraska 1 tracked deal by H.I.G. HealthBridge. Acquisitions in New York 1 tracked deal by H.I.G. HealthBridge.

Selling a company? Get in front of buyers like H.I.G. HealthBridge

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →